false
0001356570
00-0000000
0001356570
2025-10-09
2025-10-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October 9, 2025
WNS (HOLDINGS) LIMITED
(Exact name of registrant as specified in its charter)
| Jersey, Channel Islands |
001-32945 |
Not Applicable |
(State or other jurisdiction of
incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer
Identification No.) |
Gate
4, Godrej & Boyce Complex
Pirojshanagar, Vikhroli
(W) Mumbai, India |
400 079 |
| HYLO, 23rd Floor, 103-105 Bunhill
Row, Old street London |
ECY1Y 8LZ |
| 515 Madison Avenue, 8th Floor, New York,
NY |
10022 |
| (Addresses of principal executive offices) |
(Zip codes) |
+91-22-6826-2100
(Registrant’s telephone number, including area
code)
Not Applicable
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
| Ordinary share, par value 10 pence per share |
|
WNS |
|
The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
| Item 7.01 |
Regulation FD Disclosure. |
On October 9, 2025, WNS (Holdings)
Limited, a public company incorporated under the laws of the Bailiwick of Jersey (the “Company” or “WNS”),
issued a press release with respect to the matters described in Item 8.01 of this Current Report on Form 8-K. A copy of the press release
is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information in this Item
7.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that
section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities
Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.
As previously disclosed on
a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 7, 2025, the
Company entered into a Transaction Agreement (the “Agreement”) with Capgemini S.E., a société européenne
organized under the laws of France (the “Buyer”), providing for the acquisition of the Company by the Buyer, which
is expected to be implemented by means of a scheme of arrangement (the “Scheme”) under the Companies (Jersey) Law 1991
(the “Transaction”).
On October 9, 2025, at the
hearing of the Royal Court of Jersey (the “Court”) of the application to sanction the Scheme, the Court sanctioned
the Scheme. Following receipt of the Scheme sanction, the Company expects that the Transaction will close on October 17, 2025, following
the delivery of a copy of the court order to the Jersey registrar.
Forward-Looking Statements
This Current Report on Form
8-K includes “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements generally include statements
related to the proposed Transaction, including the expected closing timing. These forward-looking statements are based on the Company’s
current expectations, estimates and projections regarding, among other things, the expected Transaction closing date and the potential
benefits of the Transaction, the Company’s business and industry, and management’s beliefs and certain assumptions made by
the Company, all of which are subject to change. Forward-looking statements often contain words such as “expect,” “anticipate,”
“intend,” “aims,” “plan,” “believe,” “could,” “seek,” “see,”
“will,” “may,” “would,” “might,” “considered,” “potential,” “estimate,”
“continue,” “likely,” “expect,” “target,” “project,” or similar expressions
or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. Forward-looking
statements inherently involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied
by such statements. Such risks and uncertainties include but are not limited to: the Transaction will not be consummated on a timely
basis or at all; the possibility that any or all of the various conditions to the consummation of the Transaction may not be satisfied
or waived; the occurrence of any event, change or other circumstance that could give rise to the termination of the Agreement; the effect
of the announcement or pendency of the proposed Transaction on the Company’s business relationships, operating results, and business
generally; risks that the proposed Transaction disrupts the Company’s current plans and operations; potential difficulties in the
Company’s employee retention as a result of the proposed transaction; there may be liabilities that are not known, probable or
estimable at this time or unexpected costs, charges or expenses; the Transaction may result in the diversion of management’s time
and attention to issues relating to the Transaction; there may be significant transaction costs in connection with the Transaction; unfavorable
outcome of legal proceedings that may be instituted against the Company following the announcement of the Transaction; and the risk that
the Company’s stock price may decline significantly if the proposed Transaction is not consummated. These risks, as well as other
risks associated with the Transaction, are more fully discussed in the Scheme Document. In addition, a number of important factors could
cause the Company’s actual future results and other future circumstances to differ materially from those expressed in any forward-looking
statements, including but not limited to those important factors discussed in Part I, Item 1A “Risk Factors” in the Company’s
Annual Report on Form 10-K for the fiscal year ended March 31, 2025, as any such factors may be updated from time to time in its other
filings with the SEC, accessible on the SEC’s website at www.sec.gov, and the Company’s investor relations site at https://ir.wns.com.
These forward-looking statements speak only as of the date they are made, and, except as may be required under applicable law, the Company
undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or
otherwise.
| Item 9.01. |
Financial Statements and Exhibits. |
| Exhibit |
Description |
| 99.1 |
Press Release, dated October 9, 2025, issued by WNS |
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
WNS (HOLDINGS) LIMITED
(Registrant) |
| |
|
|
| |
|
|
| Date: October 9, 2025 |
By: |
/s/ Gopi Krishnan |
| |
|
Gopi Krishnan |
| |
|
General Counsel |
